3D Systems Announces US FDA Clearance Expanding VSP Orthopedics Indications to Include Skeletally Mature Adolescents

ROCK HILL, SC, USA, Dec 16, 2025 – 3D Systems (NYSE: DDD) today announced that the U.S. Food and Drug Administration has granted 510(k) clearance expanding the indications for its VSP Orthopedics virtual surgical planning and patient-specific instrumentation platform to include skeletally mature adolescents of normal bone stature, in addition to adults. Key Investment Highlights Ben Johnson, senior vice […]